Alphabet, Intel Earnings Take Center Stage for AI Trade This Week
As the US earnings season accelerates, investor attention is turning to results from Alphabet and Intel that could set the tone for the broader AI trade. The reports follow weeks of volatility in chip stocks and come as Wall Street weighs how much further AI-linked spending can run.
As the US earnings season picks up pace, investors are zeroing in on results due from Alphabet and Intel, seen as a key signal for the direction of AI-related stocks this week. Both companies' returns on artificial-intelligence infrastructure spending are under close scrutiny.
Analysts say the reports will shape not just perceptions of the two companies individually, but broader market sentiment on how sustainable AI-linked spending really is. Recent volatility in chipmaker shares has sharpened that focus heading into the releases.
Market watchers say strong numbers could reignite a rally in technology stocks, while disappointing figures risk reinforcing the caution that has crept into AI-themed investing over recent weeks.
Read next
Samsung Biologics makes $1.8 billion all-cash offer for Switzerland's PolyPeptide Group
South Korea's Samsung Biologics announced an all-cash bid of 1.46 billion Swiss francs ($1.8 billion) for Switzerland's PolyPeptide Group. The deal is seen as a move to expand Samsung's pharmaceutical manufacturing supply chain.
TSMC accelerates Arizona factory buildout on AI chip demand
Wall St Ends Day and Week Lower as Chip Sell-Off Broadens
AI demand drives Singapore GDP but chipmakers take a hard hit
